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Blast and burn injuries to the eye caused by explosions during combat operations or terrorist attacks are devastating injuries, and in eyes that can be saved, the major causes of vision impairment are excessive corneal scarring and neovascularization. Unfortunately, no approved drugs have been shown to improve vision outcome in eyes with these types of corneal injuries. However, decades of clinical experience and laboratory research have shown that the key to improving vision outcome is to improve the quality of corneal wound healing. (1) , (2) , (3) Our overall objective is to develop new drugs that use the emerging technology of RNA-interference (RNAi) to reduce vision impairment following corneal injuries by reducing expression of genes that stimulate formation of corneal scar (corneal haze). (4) We reported previously that corneal scarring is primarily up-regulated by the actions of transforming growth factor beta (TGFb), which stimulates corneal cells by binding to the TGFb type II receptor (TGFbRII) and inducing expression of connective tissue growth factor (CTGF). (5) CTGF then directly up-regulates synthesis of collagen scar and induces transformation of fibroblasts into myofibroblasts. Our approach is to design and test small interfering RNAs (siRNA) that will selectively reduce the level of expression of these three key proteins that stimulate corneal scar formation, and thereby, reduce vision loss. We focused on siRNAs because they are the most potent and selective of all gene-targeted, oligonucleotide-based drug approaches (better than ribozymes, antisense oligonucleotides (ASO), or microRNAs). (4) We will accomplish this objective in three specific aims. First, we will design and test siRNAs that selectively target the mRNAs of each of the three target genes, TGFb, TGFbRII and CTGF, using cultures of rabbit corneal fibroblasts (RCF). We will then test the optimal siRNA for each gene when formulated into double and triple combinations using cultures of RCF to obtain the maximum knock-down of collagen synthesis. Second, we will test the two most effective siRNA combinations for reduction of corneal scarring (haze) using the rabbit models of blast and burn corneal injuries. Third, we will compare the effectiveness of siRNAs oligonucleotides and AAV-vectored siRNAs in rabbit models of blast and burn corneal injuries for reduction of corneal scarring (haze).
BODY
We accomplished all the primary objectives for the second year of this project, and we are on schedule to begin the next phase of developing an effective antiscarring drug therapy for corneal blast and burn injuries. Starting with in vitro results and by using computational analysis, we generated two siRNA triple combinations -an "Effective" with optimal synergy and an "Ineffective" with poor synergy among its individual sequences. The efficient combination led to significant reduction in the steady state levels of the target growth factors and of the downstream mediators like Collagen-I and SMA and outperformed the ineffective combination. Employing ex vivo organ culture and in vivo animal testing, we were able to establish a method to deliver the triple combination using nanoparticles. The result from this study paves the way towards developing a multi target approach for the reduction of corneal haze and perhaps of other scarring processes affecting the skin.
Objective 1a. Test the previously identified efficient triple combination in low passage cultures of rabbit corneal fibroblasts for consistency in giving high knockdown percentages of the target growth factors and their downstream mediators like collagen and alpha Smooth Muscle Actin.
Low passage number rabbit corneal fibroblast cultures were grown to near confluency in T-75 culture flasks in DMEM supplemented with 10% newborn calf serum (NCS). The cells were harvested with trypsin/EDTA solution and 100 ul of resuspended cell suspension containing ~10 5 were seeded into cells 96 well culture plates in DMEM medium containing 10% NCS. When the cells reached initial confluency, the medium was removed and replaced with serum-free DMEM. After 48 hours of culture, estradiol and TGFB1 was added to the medium. After 24 hours of incubation, a second dose of estradiol and TGFb1 was given to the cells and the cells were transfected with the triple siRNA combination using the optimized transfection reagent and after 6 hours of incubation with the siRNA/transfection reagent, the medium was removed and replaced with DMEM. After a further 24 hours of incubation a third dose of estradiol and TGFB1 was given. After 24 hours, RNA was collected. cDNA library was generated and qRT PCR was performed to analyze the levels of target growth factors and downstream mediators. Cultures of Rabbit corneal fibroblasts stimulated with TGFB1 and Estradiol were transfected with the triple siRNA combination (15nM, 30nM, 60nM and 90nM) using Mirus transfection reagent. The RNA samples were collected 48 hours after transfection and were analyzed using qRT PCR. On a similar experiment, cells were dosed with increasing concentrations of siRNA triple combination (90nM to 180nM) and cell viability was assessed using the MTS assay. The knockdown percentages of a) TGFB1, b) TGFBR2 and c) CTGF are plotted for the identified synergistic triple combination (T1R2C1). All expressions were normalized to 18S rRNA. The knockdown percentages were calculated with respect to a scrambled siRNA control. d) The percentage of viable rabbit corneal epithelial cells after treating with increasing concentrations of the synergistic triple combination (T1R2C1).
Figure 2. Reduction of Downstream mediators by the Synergistic Triple combination (T1R2C1).
Cultures of Rabbit corneal fibroblasts stimulated with TGFB1 and Estradiol were transfected with the triple siRNA combination (90nM) using Mirus transfection reagent. The RNA samples were collected 48 hours after transfection and were analyzed using qRT PCR. The RNA level reduction percentages of a) Collagen-I and b) SMA are plotted for the identified synergistic triple combination (T1R2C1). All expression levels were normalized to 18S rRNA. The knockdown percentages were calculated with respect to a scrambled siRNA control. For the migration assay, a circular region in the middle of the well was removed using a gel removal solution provided with the Radius® cell migration kit. Panels d) -g) show migration assay results comparing cells alone and synergistic triple combination (T1R2C1) treatment wells. c) gives the percentage area of cells from the migration assays calculated through image analysis from 3 replicate wells.
Objective 1b. Assess the effectiveness of nanoparticles complexed with siRNAs to deliver the siRNAs to corneal cells in rabbit eyes.
We had previously assess the effectiveness of iontophoretic delivery of small oligonucleotide sequences (antisense oligonucleotides, ASOs) into rabbit corneal cells and found that technique was very effective in delivering ASOs into the stroma and even into the endothelial cell layer. However, that technique requires the use of a specialized iontophoresis cell that attaches to the cornea surface and a low voltage DC power supply to deliver the electrical current that moves the charged ASOs into the cornea.
To simplify the delivery approach, we assessed the effect of nanoparticles complexed with siRNAs for delivery to rabbit corneal cells. As shown in Figure 3 , we generated nanocarrier particles complexed with siGLO which is a fluoresceinlabeled siRNA that is a surrogate for our siRNAs targeting the three target genes. The siGLO complexed to nanocarrier particles that we generated with a commercially available kit of biodegradable polymers were tested in vitro using fresh rabbit globes that were ablated by excimer laser to simulate a corneal blast or burn wound. The basic in vitro test model consisted of topically applying the siGLO reporter oligo complexed to nanocarrier particles for 1 minute to the ablated area with the aid of a 14 mm vacuum trephine collar attached to the cornea. The corneas were placed in 6-well culture plates and maintained for several hours to assess uptake of the fluorescein-labeled siRNA nanocarrier particles (panel A). As seen in panel B, the uptake of siGLO when applied to the corneas without nanocarrier particles was very minimal and typically limited to the upper 1/3 of the corneal stroma. In marked contrast, application of the siGLO complexed to nanocarrier particles (panel C) after brief pretreatment of the corneas with a very dilute EDTA solution to increase permeability of the epithelial cell layer, or in panel D without EDTA pretreatment showed extensive fluorescence even to the level of Descemet's membrane, demonstrating penetration of the siGLO throughout all layers of the rabbit corneas.
These results indicate that topical delivery of siRNAs to corneas wounded by blast injuries can be accomplished rapidly and with essentially no specialized instruments when the siRNAs are complexed with nanocarrier particles. These results will be a great advantage in the next series of experiments when we treat rabbit corneas following excimer laser ablation with the triple combination of siRNAs. Objective 1c -To confirm previously reported significant reduction of the downstream mediator of scarring, smooth muscle actin (SMA), by using immunohistochemistry. Also, compare the efficacy of the efficient triple combination to an inefficient triple combination with poor synergism between the siRNA sequences to knockdown collagen.
Low passage number rabbit corneal fibroblast cultures were grown to near confluency in T-75 culture flasks in DMEM supplemented with 10% newborn calf serum (NCS). The cells were harvested with trypsin/EDTA solution and 100 ul of resuspended cell suspension containing ~10 5 were seeded into cells 96 well culture plates in DMEM medium containing 10% NCS. When the cells reached initial confluency, the medium was removed and replaced with serum-free DMEM. After 48 hours of culture, estradiol and TGFB1 was added to the medium. After 24 hours of incubation, a second dose of estradiol and TGFb1 was given to the cells and the cells were transfected with the triple siRNA combination using the optimized transfection reagent and after 6 hours of incubation with the siRNA/transfection reagent, the medium was removed and replaced with DMEM. After a further 24 hours of incubation a third dose of estradiol and TGFB1 was given. After 24 hours, the cells were fixed in 4% paraformaldehyde for 10 minutes. They were then washed in PBS and treated with cold methanol for 15 minutes at -20C. They were washed again in PBS and blocked in goat serum for 1 hour. The samples were incubated with an SMA antibody congujated with Cy3 for 1 hour. The cells were wash again in PBS before mounting them with DAPI. They were imaged using a confocal microscope for taking image. Step2. The image was split into 2 channels -red and blue. SMA was detected by the red channel and the blue channel detected by the DAPI stained nuclei. The number of cells is counted using the cell counter tool. Step3. A color threshold was applied so that only the SMA stained areas are detected. Finally, the percent area stained by SMA was measured and expressed in terms of the number of cells. The graph comparing the reduction of SMA in cells treated with synergistic and non-synergistic siRNA triple combination is given in Figure 4 -e. It comports with the previously obtained RNA level knockdown measured using qRT-PCR.
Objective 1d-To study the change in expression of CTGF and TGFB1 after excimer ablation in rabbit corneas after ablation at different time points to improve siRNA targeting knowledge.
An excimer laser was used to reproducibly create deep (1/3 the total depth of the cornea), bilateral, PTK ablations (8 mm diameter) to the central cornea of adult NZW rabbits. After ablation, rabbits were euthanized at 2 different time points, day 1 and day 2. A total of 4 rabbits were used for each time point. The cornea was excised and RNA from the different layers (epithelium, stroma and endothelium) were extracted. A cDNA library was generated which was used to probe the expressions of TGFB1 and CTGF. On day 1, the highest expression of CTGF mRNA was in the endothelium, followed by stroma and finally the epithelium. However on Day 2, the stroma had the greatest levels of expression of CTGF. On day1, there was very little expression TGFB1 mRNA throughout all cell layers of the cornea. On Day 2, there was a large increase in the production of TGFB1. The highest expression of TGFB1 mRNA was found in the endothelium followed by stroma and epithelium. Objective 1e -To optimize the parameters of the in-vivo confocal microscope using rabbit globes. Commercially available rabbit globes were ordered from Pelfreeze. They were then used to optimize the various parameters of the invivo confocal microscope so that optimized images of the three different layers can be visualized. These settings will be used to analyze of the ability of the triple combination of the siRNAs to reduce haze in rabbit corneas after ablation. Cultures of rabbit corneal fibroblasts (RbCF) were established by outgrowth from rabbit whole eyes, as described previously (Woost, Jumblatt, Eiferman, & Schultz, 1992) . Briefly, epithelial and endothelial cells were removed from corneas, the stroma was cut into cubes of approximately 1 mm 3 , placed in culture medium consisting of equal parts Dulbecco's Modified Eagle Medium (DMEM), with 4.5g/L Glucose and 1g/L L-glutamine. Medium was supplemented with 10% heat-inactivated normal calf serum and 1× antibiotic-antimycotic (Gibco BRL). Cell from cultures between passages 2 and 5 were used for all experiments. To increase the expression of TGFB1, TGFBR2 and CTGF, RbCF were place in serum-free media for 48 hours, then the medium was replaced by 8ug/ml of estradiol (Sigma, St. Louis, MO) and TGF-B1 (R&D Systems, Minneapolis, MN) in DMEM. The cells were dosed twice with the estradiol before transfection of the siRNA (Takahashi et al., 1994; Wira, 2002) . For the migration assay, RadiusTM Cell Migration Plate (Cell biolabs, San Diego, CA) was procured and used according to manufacturer's protocol. Images were taken at 10x magnification and analyzed using Adobe Photoshop. Figure 13 . For the migration assay, a circular region in the middle of the well was removed using a gel removal solution provided with the Radius® cell migration kit. Panels a) -d) show migration assay results comparing cells alone and synergistic triple combination (T1R2C1) treatment wells. e) gives the percentage area of cells from the migration assays calculated through image analysis from 3 replicate wells.
Apart from reducing the above downstream mediators, the synergistic triple combination (T1R2C1) was also able to significantly inhibit the migration of cells within two days post transfection. The percentage area of cells which was calculated digitally from the three replicates was used as a measure of migration (Figure 3-c) 
e)
Objective 1g -Observe and evaluate the effects of a topical application of the previously optimized siRNA-nanocarrier complex post wounding in a rabbit model Adult New Zealand Rabbits free of disease were used and treated according to ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Excimer ablation and collection of corneas was performed as previously described (Netto et al., 2006) . Briefly, rabbits were anesthetized with isoflurane inhalation, and proparacaine eye drops provided topical anesthesia. Laser ablations were performed to both eyes of each rabbit with a Summit SVS exicimer laser that is committed to animal vision research. Using the laser in phototherapeutic keratectomy mode, the central 6 mm diameter area of the cornea was be ablated at a dose of 160mJ/cm2 to an initial depth of 80 microns to remove the epithelium and then the final 45 microns were ablated by placing a mesh over the cornea to make an uneven ablation. The eyes were pretreated with 50uM EDTA for 10 minutes. A total of 150ul of the nanoparticle complexed with the siRNA triple combination was added to the right eye while the left eye was treated with the vehicle control and was considered as a paired negative control. The eyes were held open for 3 minutes to allow the nanoparticle to penetrate the stroma before being disturbed. No postoperative topical steroid was used to ensure that the wound healing process is not altered with anti-inflammatory agents. One and fifteen days after the treatment, corneas were collected, homogenized in a pestle with liquid nitrogen and then transferred to TRIzol. The RNA was then extracted using a hybrid RNA extraction protocol with RNeasy spin columns (Rodriguez-Lanetty, 2007).
Figure 14
-For the in vivo experiment, the corneas of 6 rabbits were unevenly ablated to 125 microns using an excimer laser. The right eye was treated with150uL of the synergistic triple combination (T1R2C1) complexed with nanoparticles and the left eye received the vehicle control. Three rabbits for each time point were sacrificed and RNA was extracted for analysis by qRT PCR at 1 and 14 days post siRNA treatment. a) gives the RNA level knockdown percentages of the target growth factors at day1 while b) gives the RNA level knockdown percentage of SMA at day15. All expressions were normalized to 18S rRNA and knockdown percentages were calculated with respect to the left eye. The corneal scarring was graded by an ophthalmologist on a scale from 0-4. The scores for both the treated and control eyes are plotted for each rabbit in c) 
